Rakovina Therapeutics Showcases Potent AI-Developed ATR Inhibitors with CNS Penetrance at AACR-NCI-EORTC International Conference

Rakovina Therapeutics Showcases Potent AI-Developed ATR Inhibitors with CNS Penetrance at AACR-NCI-EORTC International Conference GlobeNewswire October 27, 2025 VANCOUVER, British Columbia, Oct. 27, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV)(FSE: 7JO0) is pleased to announce the successful presentation of new data at the AACR-NCI-EORTC International Conference on Molecular Targets […]

Jasper Therapeutics, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – JSPR

The DJS Law Group reminds investors of a class action lawsuit against Jasper Therapeutics, Inc. (“Jasper” or “the Company”) (NASDAQ: JSPR ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of JSPR during the

Quanex Building Products Corporation Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – NX

The DJS Law Group reminds investors of a class action lawsuit against Quanex Building Products Corporation (“Quanex ” or “the Company”) (NYSE: NX ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of NX

NX Investors Have Opportunity to Lead Quanex Building Products Corporation Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit againstQuanex Building Products Corporation (“Quanex” or “the Company”) (NYSE: NX) forviolations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg Investors who purchased

aTyr Pharma, Inc. Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights – ATYR

The DJS Law Groupannounces that it is investigating claims on behalf of investors ofaTyr Pharma, Inc. (“aTyr” or “the Company”) (NASDAQ: ATYR) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pertinent to investors. On September 15, 2025, Reuters reported that,

Rehabilitation Expert Kelly Schneider of Evansville, IN, Explains Therapy Services for HelloNation

EVANSVILLE, Ind., Oct. 27, 2025 (GLOBE NEWSWIRE) — When should someone consider therapy services, and how do they know which type of therapy is best? That question is answered in a HelloNation article featuring Rehabilitation Expert Kelly Schneider of Easterseals Rehabilitation Center in Evansville, Indiana. The feature explains the different forms of therapy available, how

Rehabilitation Expert Kelly Schneider of Evansville, IN, Explains Therapy Services for HelloNation

Rehabilitation Expert Kelly Schneider of Evansville, IN, Explains Therapy Services for HelloNation GlobeNewswire October 27, 2025 EVANSVILLE, Ind., Oct. 27, 2025 (GLOBE NEWSWIRE) — When should someone consider therapy services, and how do they know which type of therapy is best? That question is answered in a HelloNation article featuring Rehabilitation Expert Kelly Schneider of

Roofing Expert Michael St. Germain Discusses Common Myths About Roof Replacements for HelloNation

Roofing Expert Michael St. Germain Discusses Common Myths About Roof Replacements for HelloNation GlobeNewswire October 27, 2025 AUBURN, N.Y., Oct. 27, 2025 (GLOBE NEWSWIRE) — Many homeowners believe that a roof only needs replacement when shingles start falling off or leaks appear, but that assumption can lead to expensive problems down the line. In a

ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit againstaTyr Pharma, Inc. (“aTyr” or “the Company”) (NASDAQ: ATYR)forviolations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg Investors who purchased the Company's

Scroll to Top